A detailed history of Susquehanna International Group, LLP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 123,817 shares of BPMC stock, worth $11.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
123,817
Previous 61,581 101.06%
Holding current value
$11.2 Million
Previous $6.64 Million 72.49%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$84.1 - $120.5 $5.23 Million - $7.5 Million
62,236 Added 101.06%
123,817 $11.4 Million
Q2 2024

Aug 15, 2024

SELL
$85.18 - $108.78 $5.79 Million - $7.39 Million
-67,916 Reduced 52.45%
61,581 $6.64 Million
Q1 2024

May 07, 2024

BUY
$73.17 - $99.79 $2.95 Million - $4.02 Million
40,254 Added 45.11%
129,497 $12.3 Million
Q4 2023

Feb 14, 2024

SELL
$43.96 - $92.84 $9.95 Million - $21 Million
-226,338 Reduced 71.72%
89,243 $8.23 Million
Q3 2023

Nov 14, 2023

BUY
$46.9 - $66.0 $8.33 Million - $11.7 Million
177,592 Added 128.7%
315,581 $15.8 Million
Q2 2023

Aug 11, 2023

SELL
$42.2 - $66.37 $904,894 - $1.42 Million
-21,443 Reduced 13.45%
137,989 $8.72 Million
Q1 2023

May 16, 2023

BUY
$37.97 - $50.0 $3.72 Million - $4.9 Million
98,055 Added 159.76%
159,432 $7.17 Million
Q4 2022

Feb 14, 2023

BUY
$41.06 - $66.48 $530,043 - $858,190
12,909 Added 26.63%
61,377 $2.69 Million
Q3 2022

Nov 14, 2022

BUY
$49.93 - $77.7 $847,761 - $1.32 Million
16,979 Added 53.92%
48,468 $3.19 Million
Q2 2022

Aug 15, 2022

SELL
$45.23 - $70.15 $1.76 Million - $2.74 Million
-39,019 Reduced 55.34%
31,489 $1.59 Million
Q1 2022

May 16, 2022

BUY
$54.1 - $110.08 $1.93 Million - $3.93 Million
35,704 Added 102.59%
70,508 $4.5 Million
Q4 2021

Feb 14, 2022

BUY
$94.25 - $115.99 $262,392 - $322,916
2,784 Added 8.69%
34,804 $3.73 Million
Q3 2021

Nov 15, 2021

SELL
$80.98 - $109.47 $506,529 - $684,734
-6,255 Reduced 16.34%
32,020 $3.29 Million
Q2 2021

Aug 11, 2021

BUY
$82.78 - $101.0 $2.27 Million - $2.77 Million
27,466 Added 254.1%
38,275 $3.37 Million
Q1 2021

May 17, 2021

SELL
$90.71 - $108.28 $535,551 - $639,285
-5,904 Reduced 35.33%
10,809 $1.05 Million
Q4 2020

Feb 16, 2021

SELL
$92.08 - $124.48 $78,728 - $106,430
-855 Reduced 4.87%
16,713 $1.87 Million
Q3 2020

Nov 16, 2020

SELL
$66.45 - $92.7 $1.4 Million - $1.96 Million
-21,125 Reduced 54.6%
17,568 $1.63 Million
Q2 2020

Aug 14, 2020

SELL
$57.09 - $79.27 $10.9 Million - $15.1 Million
-190,367 Reduced 83.11%
38,693 $3.02 Million
Q1 2020

May 15, 2020

BUY
$48.11 - $82.22 $8.11 Million - $13.9 Million
168,578 Added 278.72%
229,060 $13.4 Million
Q4 2019

Feb 14, 2020

BUY
$66.73 - $82.59 $1.79 Million - $2.22 Million
26,867 Added 79.93%
60,482 $4.85 Million
Q3 2019

Nov 14, 2019

BUY
$72.9 - $101.41 $100,747 - $140,148
1,382 Added 4.29%
33,615 $2.47 Million
Q2 2019

Aug 16, 2019

BUY
$73.54 - $97.8 $1.76 Million - $2.34 Million
23,915 Added 287.51%
32,233 $3.04 Million
Q1 2019

May 15, 2019

SELL
$48.7 - $86.6 $4.21 Million - $7.48 Million
-86,397 Reduced 91.22%
8,318 $666,000
Q2 2018

Aug 14, 2018

BUY
$60.96 - $101.18 $4.68 Million - $7.77 Million
76,749 Added 427.19%
94,715 $6.01 Million
Q4 2017

Feb 14, 2018

BUY
$62.91 - $88.32 $1.13 Million - $1.59 Million
17,966
17,966 $1.36 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.39B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.